glutathione pathway to triple negative cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy International Journal of Oncology
International Journal of Oncology Recent advances in targeted strategies for triple negative breast cancer Journal of Hematology & Oncology Springer Nature Link Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



